Thyme Care, a Nashville, TN-based value-based cancer care partner, raised $60M in Series B funding.
The round, which brought total capital raised to over $80M, was co-led by Town Hall Ventures and Foresite Capital, with participation from current investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Frist Cressey Ventures. David Whelan, co-founder and general partner at Town Hall Ventures, and Elizabeth Canis, executive advisor at Foresite Capital and former Elevance and UnitedHealthcare executive, will join the Thyme’s Board of Directors.
The company intends to use the funds to accelerate its national network of oncology partners in new markets and expand its comprehensive cancer care support services.
Co-founded by Robin Shah and Dr. Bobby Green, Thyme Care partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care’s approach combines a technology-enabled Care Team and integration with providers, creating a hybrid collaborative care delivery model that guides and supports the entire patient journey. Supported by the company’s purpose-built care management platform, Thyme Box, the Care Team is able to quickly gather context on a member, help manage their comorbidities and coordinate care with their providers, and quickly triage patients to their oncology practice when worrisome symptoms arise. Additional resources and support services for transportation, housing, food, behavioral health, financial assistance, palliative care and more are provided to members and their caregivers to help reduce the barriers to care.
Thyme Care empowers over 300 oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX.
FinSMEs
22/08/2023